Prenatal maternal depressive symptoms are associated with neonatal left amygdala microstructure in a sex-dependent

Niloofar Hashempour1, Jetro J Tuulari1,2,3,4, Harri Merisaari1,5

  • 1FinnBrain Birth Cohort Study, Turku Brain and Mind Center, Department of Clinical Medicine, University of Turku, Turku, Finland.

Insights

Prenatal maternal depressive symptoms (PMDS) impact infant brain development. Boys exposed to PMDS in early pregnancy showed altered amygdala microstructure, suggesting sex-specific neurodevelopmental effects.

Area of Science:

  • Neuroscience
  • Developmental Psychology
  • Maternal Health

Background:

  • Prenatal maternal depressive symptoms (PMDS) are linked to offspring neurodevelopmental changes.
  • Previous research established a connection between PMDS and infant brain development.
  • The specific impact of PMDS across different prenatal stages on amygdala microstructure is not well understood.

Purpose of the Study:

  • To investigate the association between PMDS at different gestational ages and infant amygdala microstructural properties.
  • To explore sex-dependent differences in the relationship between PMDS and amygdala development.

Main Methods:

  • Diffusion tensor imaging (DTI) was used to assess amygdala microstructure.
  • Mean diffusivity (MD) in the amygdala was measured in infants (11-54 days old).
  • PMDS were assessed at gestational weeks 14, 24, and 34.

Main Results:

  • No significant main effect of PMDS on overall amygdala MD metrics was found.
  • A significant interaction between PMDS and infant sex was observed in the left amygdala MD.
  • Male infants exposed to higher PMDS at gestational week 14 exhibited significantly higher left amygdala MD compared to females.

Conclusions:

  • Prenatal maternal depressive symptoms are associated with altered amygdala microstructure in male infants.
  • These findings highlight sex-specific effects of PMDS on early brain development.
  • The observed microstructural changes may have implications for future neuropsychiatric outcomes.